Grosset, D. G., Tyrrell, E. G., & Grosset, K. A. (2014). Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases. Journal of Rehabilitation Medicine, 47(2), 183–186. https://doi.org/10.2340/16501977-1895